Literature DB >> 28374154

Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.

Franco Rabbia1, Elisa Testa2, Chiara Fulcheri3, Elena Berra1, Silvia Di Monaco1, Michele Covella1, Marco Pappaccogli1, Silvia Monticone1, Renato Rosiello4, Denis Rossato5, Franco Veglio1.   

Abstract

INTRODUCTION: Recent anatomical and clinical studies have led to the hypothesis that in several cases of failure of response to renal denervation (RDN), the procedure has not been technically correct. AIM: To perform procedural reassessment in patients with true resistant hypertension who underwent RDN.
METHODS: We retrospectively reassessed the procedural technique of RDN in 10 true resistant hypertensive patients, comparing the sites of renal ablations with the knowledge of animal and human post mortem evidences. Procedural ablation technique was assessed in terms of number of ablations for each renal artery and site of ablation (quadrant and distance from renal ostium) by using the radiologic images of each RDN and the number of radiofrequency ablation attempts documented in the reports of each denervation session.
RESULTS: 10 patients were studied, 9 denervated with Simplicity monoelectrode catheter, 1 with multielectrode balloon technique. Responders to the procedure underwent more ablations and particularly at least a quadrant ablation in one of the kidney arteries, >2 ablations in Dorsal plus Ventral quadrants and in 67% of then >10 ablations were done in superior inferior and ventral quadrants.
CONCLUSION: This study confirms the importance of a well knowledge of renal artery anatomy and underlines the relevance of the choice of ablation sites in order to obtain a successful RDN procedure.

Entities:  

Keywords:  Invasive therapy; Renal artery; Renal sympathetic denervation; Resistant hypertension

Mesh:

Substances:

Year:  2017        PMID: 28374154     DOI: 10.1007/s40292-017-0197-0

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  23 in total

1.  2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension.

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stephane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  Blood Press       Date:  2013-12-20       Impact factor: 2.835

2.  Renal artery nerve distribution and density in the porcine model: biologic implications for the development of radiofrequency ablation therapies.

Authors:  Armando Tellez; Serge Rousselle; Taylor Palmieri; William R Rate; Joan Wicks; Ashley Degrange; Chelsea M Hyon; Carlos A Gongora; Randy Hart; Will Grundy; Greg L Kaluza; Juan F Granada
Journal:  Transl Res       Date:  2013-07-30       Impact factor: 7.012

3.  Post mortem study of the depth and circumferential location of sympathetic nerves in human renal arteries--implications for renal denervation catheter design.

Authors:  Andrew K Roy; Aurelie Fabre; Melanie Cunningham; Una Buckley; Thomas Crotty; David Keane
Journal:  Catheter Cardiovasc Interv       Date:  2015-05-27       Impact factor: 2.692

4.  Blood pressure response to renal nerve stimulation in patients undergoing renal denervation: a feasibility study.

Authors:  P Gal; M R de Jong; J J J Smit; A Adiyaman; J A Staessen; A Elvan
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

5.  Comparison of histopathologic analysis following renal sympathetic denervation over multiple time points.

Authors:  Kenichi Sakakura; Stefan Tunev; Kazuyuki Yahagi; Amanda J O'Brien; Elena Ladich; Frank D Kolodgie; Robert J Melder; Michael Joner; Renu Virmani
Journal:  Circ Cardiovasc Interv       Date:  2015-02       Impact factor: 6.546

6.  Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.

Authors:  Fadl Elmula M Fadl Elmula; Yu Jin; Wen-Yi Yang; Lutgarde Thijs; Yi-Chao Lu; Anne C Larstorp; Alexandre Persu; Marc Sapoval; Ján Rosa; Petr Widimský; Lotte Jacobs; Jean Renkin; Ondřej Petrák; Gilles Chatellier; Kazuyuki Shimada; Jiři Widimský; Kazuomi Kario; Michel Azizi; Sverre E Kjeldsen; Jan A Staessen
Journal:  Blood Press       Date:  2015-07-17       Impact factor: 2.835

7.  Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertension.

Authors:  Abraham R Tzafriri; John H Keating; Peter M Markham; Anna-Maria Spognardi; James R L Stanley; Gee Wong; Brett G Zani; Debby Highsmith; Patrick O'Fallon; Kristine Fuimaono; Felix Mahfoud; Elazer R Edelman
Journal:  Sci Transl Med       Date:  2015-04-29       Impact factor: 17.956

Review 8.  Updated ESH position paper on interventional therapy of resistant hypertension.

Authors:  Roland E Schmieder; Josep Redon; Guido Grassi; Sverre E Kjeldsen; Giuseppe Mancia; Krzysztof Narkiewicz; Gianfranco Parati; Luis Ruilope; Philippe van de Borne; Costas Tsioufis
Journal:  EuroIntervention       Date:  2013-05       Impact factor: 6.534

9.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

10.  Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model.

Authors:  Meital Cohen-Mazor; Prabodh Mathur; James R L Stanley; Farrell O Mendelsohn; Henry Lee; Rose Baird; Brett G Zani; Peter M Markham; Krishna Rocha-Singh
Journal:  J Hypertens       Date:  2014-08       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.